{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:11:07Z","timestamp":1790709067253,"version":"4.1.0"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2019,5,1]]},"DOI":"10.1001\/jamaneurol.2018.4666","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T11:01:19Z","timestamp":1551697279000},"page":"598","source":"Crossref","is-referenced-by-count":191,"title":["Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes"],"prefix":"10.1001","volume":"76","author":[{"given":"Matthew P.","family":"Pase","sequence":"first","affiliation":[{"name":"Department of Neurology, Boston University School of Medicine, Boston, Massachusetts"},{"name":"Framingham Heart Study, Framingham, Massachusetts"},{"name":"Centre for Human Psychopharmacology, Swinburne University of Technology, Hawthorn, Australia"},{"name":"Melbourne Dementia Research Centre, The Florey Institute for Neuroscience and Mental Health and The University of Melbourne, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa S.","family":"Beiser","sequence":"additional","affiliation":[{"name":"Department of Neurology, Boston University School of Medicine, Boston, Massachusetts"},{"name":"Framingham Heart Study, Framingham, Massachusetts"},{"name":"Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayandra J.","family":"Himali","sequence":"additional","affiliation":[{"name":"Department of Neurology, Boston University School of Medicine, Boston, Massachusetts"},{"name":"Framingham Heart Study, Framingham, Massachusetts"},{"name":"Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia L.","family":"Satizabal","sequence":"additional","affiliation":[{"name":"Department of Neurology, Boston University School of Medicine, Boston, Massachusetts"},{"name":"Framingham Heart Study, Framingham, Massachusetts"},{"name":"Glenn Biggs Institute for Alzheimer\u2019s and Neurodegenerative Diseases, University of Texas Health Sciences Center, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo J.","family":"Aparicio","sequence":"additional","affiliation":[{"name":"Department of Neurology, Boston University School of Medicine, Boston, Massachusetts"},{"name":"Framingham Heart Study, Framingham, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"DeCarli","sequence":"additional","affiliation":[{"name":"Framingham Heart Study, Framingham, Massachusetts"},{"name":"Department of Neurology, School of Medicine & Imaging of Dementia and Aging Laboratory, Center for Neuroscience, University of California Davis, Sacramento, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Ch\u00eane","sequence":"additional","affiliation":[{"name":"Inserm Unit 1219 Bordeaux Population Health, CIC 1401-EC (Clinical Epidemiology), University of Bordeaux, ISPED (Bordeaux School of Public Health), Bordeaux University Hospital, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Dufouil","sequence":"additional","affiliation":[{"name":"Inserm Unit 1219 Bordeaux Population Health, CIC 1401-EC (Clinical Epidemiology), University of Bordeaux, ISPED (Bordeaux School of Public Health), Bordeaux University Hospital, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudha","family":"Seshadri","sequence":"additional","affiliation":[{"name":"Department of Neurology, Boston University School of Medicine, Boston, Massachusetts"},{"name":"Framingham Heart Study, Framingham, Massachusetts"},{"name":"Glenn Biggs Institute for Alzheimer\u2019s and Neurodegenerative Diseases, University of Texas Health Sciences Center, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"noi180106r1","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nbt.1641","article-title":"Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations.","volume":"28","author":"Rissin","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"6","key":"noi180106r2","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1021\/ac103161b","article-title":"Simultaneous detection of single molecules and singulated ensembles of molecules enables immunoassays with broad dynamic range.","volume":"83","author":"Rissin","year":"2011","journal-title":"Anal Chem"},{"issue":"2","key":"noi180106r3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/alzrt163","article-title":"Plasma tau levels in Alzheimer\u2019s disease.","volume":"5","author":"Zetterberg","year":"2013","journal-title":"Alzheimers Res Ther"},{"issue":"7","key":"noi180106r4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis.","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol"},{"issue":"12","key":"noi180106r5","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.jalz.2016.06.001","article-title":"Levels of tau protein in plasma are associated with neurodegeneration and cognitive function in a population-based elderly cohort.","volume":"12","author":"Dage","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"4","key":"noi180106r6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease.","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"9","key":"noi180106r7","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1001\/jamaneurol.2017.1359","article-title":"Association of plasma total tau level with cognitive decline and risk of mild cognitive impairment or dementia in the Mayo Clinic study on aging.","volume":"74","author":"Mielke","year":"2017","journal-title":"JAMA Neurol"},{"issue":"17","key":"noi180106r8","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1212\/WNL.0000000000003246","article-title":"Plasma tau in Alzheimer disease.","volume":"87","author":"Mattsson","year":"2016","journal-title":"Neurology"},{"issue":"3","key":"noi180106r9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2105\/AJPH.41.3.279","article-title":"Epidemiological approaches to heart disease: the Framingham Study.","volume":"41","author":"Dawber","year":"1951","journal-title":"Am J Public Health Nations Health"},{"issue":"4","key":"noi180106r10","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/0091-7435(75)90037-7","article-title":"The Framingham Offspring Study. design and preliminary data.","volume":"4","author":"Feinleib","year":"1975","journal-title":"Prev Med"},{"issue":"11","key":"noi180106r11","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/aje\/kwm021","article-title":"The Third Generation Cohort of the National Heart, Lung, and Blood Institute\u2019s Framingham Heart Study: design, recruitment, and initial examination.","volume":"165","author":"Splansky","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"6","key":"noi180106r12","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1056\/NEJMoa1504327","article-title":"Incidence of dementia over three decades in the Framingham Heart Study.","volume":"374","author":"Satizabal","year":"2016","journal-title":"N Engl J Med"},{"issue":"7","key":"noi180106r14","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s disease.","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"4","key":"noi180106r15","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/WAD.0b013e31827bde32","article-title":"Defining MCI in the Framingham Heart Study Offspring: education versus WRAT-based norms.","volume":"27","author":"Ahl","year":"2013","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"2","key":"noi180106r16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0887-6177(03)00039-8","article-title":"Trail Making Test A and B: normative data stratified by age and education.","volume":"19","author":"Tombaugh","year":"2004","journal-title":"Arch Clin Neuropsychol"},{"issue":"3","key":"noi180106r18","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.neuroimage.2009.02.018","article-title":"Multi-atlas based segmentation of brain images: atlas selection and its effect on accuracy.","volume":"46","author":"Aljabar","year":"2009","journal-title":"Neuroimage"},{"issue":"6","key":"noi180106r19","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1212\/WNL.52.6.1158","article-title":"The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer\u2019s disease.","volume":"52","author":"Delacourte","year":"1999","journal-title":"Neurology"},{"issue":"4","key":"noi180106r20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes.","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"issue":"2","key":"noi180106r21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/(ISSN)1097-0258","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"issue":"1","key":"noi180106r22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/sim.v30.1","article-title":"Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.","volume":"30","author":"Pencina","year":"2011","journal-title":"Stat Med"},{"issue":"19","key":"noi180106r23","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1002\/(ISSN)1097-0258","article-title":"Confidence interval estimates of an index of quality performance based on logistic regression models.","volume":"14","author":"Hosmer","year":"1995","journal-title":"Stat Med"},{"issue":"4","key":"noi180106r24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.neurobiolaging.2004.05.004","article-title":"Measures of brain morphology and infarction in the Framingham Heart Study: establishing what is normal.","volume":"26","author":"DeCarli","year":"2005","journal-title":"Neurobiol Aging"},{"issue":"7","key":"noi180106r25","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1161\/STROKEAHA.117.013369","article-title":"Role of improved vascular health in the declining incidence of dementia.","volume":"48","author":"Pase","year":"2017","journal-title":"Stroke"},{"issue":"12","key":"noi180106r26","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease.","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat Genet"},{"issue":"1","key":"noi180106r27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13195-017-0288-0","article-title":"Cognitive and imaging markers in non-demented subjects attending a memory clinic: study design and baseline findings of the MEMENTO cohort.","volume":"9","author":"Dufouil","year":"2017","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"noi180106r28","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2217\/17520363.2.4.363","article-title":"Tau as a biomarker of neurodegenerative diseases.","volume":"2","author":"Schraen-Maschke","year":"2008","journal-title":"Biomark Med"},{"issue":"3","key":"noi180106r29","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.resuscitation.2012.07.027","article-title":"Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: results of a pilot study.","volume":"84","author":"Randall","year":"2013","journal-title":"Resuscitation"},{"issue":"4","key":"noi180106r30","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3233\/JAD-161114","article-title":"Plasma tau association with brain atrophy in mild cognitive impairment and Alzheimer\u2019s disease.","volume":"58","author":"Deters","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"noi180106r31","doi-asserted-by":"publisher","first-page":"9529","DOI":"10.1038\/s41598-017-08779-0","article-title":"Tau plasma levels in subjective cognitive decline: results from the DELCODE study.","volume":"7","author":"M\u00fcller","year":"2017","journal-title":"Sci Rep"},{"issue":"3","key":"noi180106r32","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging\u2013Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease.","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"228","key":"noi180106r33","doi-asserted-by":"publisher","first-page":"228fs13","DOI":"10.1126\/scitranslmed.3007941","article-title":"The A4 study: stopping AD before symptoms begin?","volume":"6","author":"Sperling","year":"2014","journal-title":"Sci Transl Med"},{"issue":"3","key":"noi180106r34","doi-asserted-by":"publisher","first-page":"e1002254","DOI":"10.1371\/journal.pmed.1002254","article-title":"APOE-related risk of mild cognitive impairment and dementia for prevention trials: an analysis of four cohorts.","volume":"14","author":"Qian","year":"2017","journal-title":"PLoS Med"},{"key":"noi180106r13","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychatric Association","year":"2000","edition":"4th ed"},{"key":"noi180106r17","volume-title":"A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary","author":"Strauss","year":"2006"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamaneurology\/article-pdf\/76\/5\/598\/17579684\/jamaneurology_pase_2019_oi_180106.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T11:02:21Z","timestamp":1557745341000},"score":1,"resource":{"primary":{"URL":"http:\/\/archneur.jamanetwork.com\/article.aspx?doi=10.1001\/jamaneurol.2018.4666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,1]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2018.4666","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735241247.793565964","asserted-by":"object"}]},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,1]]}}}